Atezolizumab/Bevacizumab Responder or Non-responder in Patients with Hepatocellular Carcinoma
Comparing the Gut Microbiota in Hepatocellular Carcinoma Patients: Atezolizumab/Bevacizumab Responders vs. Non-Responders.